Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial.

By L. Wallentin, S. Yusuf, M. Ezekowitz, M. Alings, M. Flather, M. Franzosi, P. Pais, A. Dans, J. Eikelboom, J. Oldgren and 4 more. The Lancet, 2010

997 citations recorded by the source corpus.